Literature DB >> 2996410

Treatment of infections in patients with the acquired immunodeficiency syndrome.

D Armstrong, J W Gold, J Dryjanski, E Whimbey, B Polsky, C Hawkins, A E Brown, E Bernard, T E Kiehn.   

Abstract

The microorganisms that regularly infect patients with the acquired immunodeficiency syndrome (AIDS) have become well recognized. Most take advantage of defects in T-lymphocyte function, but others, such as Streptococcus pneumoniae and Haemophilus influenzae, take advantage of B-cell defects. Still others, such as Staphylococcus aureus and Shigella species, occur or persist for reasons that are unclear. Infections with organisms associated with hospitalization and medical procedures are also seen and should be anticipated. Among the infections taking advantage of T-cell defects, Pneumocystis carinii pneumonia is the most commonly diagnosed, but cytomegalovirus infection may be equally common. Disseminated Mycobacterium avium-intracellulare infection has been found in one half of our patients at postmortem examination. The retrovirus responsible for AIDS commonly infects the central nervous system, as does Toxoplasma gondii. Although candida infections are common, dissemination is uncommon. Many of the infections respond to appropriate therapy but tend to recur when treatment is stopped. Often treatment courses must be prolonged even beyond those used in other immunocompromised hosts.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Americas; Central Nervous System Effects; Developed Countries; Developing Countries; Diseases; Hiv Infections; Infections; Neurologic Effects; North America; Northern America; Parasitic Diseases; Treatment; United States; Viral Diseases

Mesh:

Year:  1985        PMID: 2996410     DOI: 10.7326/0003-4819-103-5-738

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  53 in total

1.  Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.

Authors:  S Majumdar; D Flasher; D S Friend; P Nassos; D Yajko; W K Hadley; N Düzgüneş
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Interaction between fluconazole and rifampicin.

Authors:  R J Coker; D R Tomlinson; J Parkin; J R Harris; A J Pinching
Journal:  BMJ       Date:  1990-10-06

Review 3.  Disseminated Pneumocystis carinii in a patient receiving aerosolized pentamidine prophylaxis.

Authors:  S M Berman; B Shah; F A Wyle; M Dacosta-Iyer; D M McRae
Journal:  West J Med       Date:  1990-07

4.  Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 5.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

6.  Laboratory diagnosis of mycobacterial infections in patients with acquired immunodeficiency syndrome.

Authors:  T E Kiehn; R Cammarata
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

7.  Targeting the rpoB gene using nested PCR-restriction fragment length polymorphism for identification of nontuberculous mycobacteria in hospital tap water.

Authors:  Ji-Hyun Shin; Hae-Kyung Lee; Eun-Jin Cho; Jae-Yon Yu; Yeon-Ho Kang
Journal:  J Microbiol       Date:  2008-12-24       Impact factor: 3.422

Review 8.  Antigens of the Mycobacterium avium, Mycobacterium intracellulare complex.

Authors:  S L Morris
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

9.  Rapid identification using a specific DNA probe of Mycobacterium avium complex from patients with acquired immunodeficiency syndrome.

Authors:  T E Kiehn; F F Edwards
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

10.  In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis.

Authors:  R T Mehta; A Keyhani; T J McQueen; B Rosenbaum; K V Rolston; J J Tarrand
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.